Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

2024 SABCS Annual Meeting Insights Hub
Avatar

SABCS 2024 Insights: EMBER-3 Trial - Imlunestrant Monotherapy and Combined With Abemaciclib in ER+/HER2- aBC

By 2024 SABCS Annual Meeting Insights Hub FEATURING Komal Jhaveri
By 2024 SABCS Annual Meeting Insights Hub FEATURING Komal Jhaveri
270 views
January 8, 2025
Comments 0
Login to view comments. Click here to Login

Featured Video

14:18
Incyte

Early Intervention in Chronic GVHD: Evaluating Efficacy and Safety O…

Feat. H. Ali

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Breast
13:16

SABCS 2024 Insights: EMBER-3 Trial - Imlunestrant Monotherapy and Co…

2024 SABCS Annual Meeting Insights Hub

K. Jhaveri

270 views
06:39

FDA Approval Clinical Implications: Inavolisib With Palbociclib and …

Memorial Sloan Kettering Cancer Center

K. Jhaveri

1.5K views
06:55

ESMO 2023 Insights: "EMBER Study - Imlunestrant+/-Everolimus or Alpe…

Insights from 2023 ESMO Annual Meeting

K. Jhaveri

160 views
21:26

Early Diagnosis and Updates in Breast Cancer

Memorial Sloan Kettering Cancer Center

V. Sacchini

173 views
27:27

ASCO 2022 HR+ Breast Cancer Updates

Nebraska Oncology Society

C. Dang

601 views
05:51

ASCO 2022 on the Phase 3 DESTINY-Breast 03 Trial: HER2+ BC Updates

Nebraska Oncology Society

C. Dang

57 views
09:47

ASCO 2022 on the Phase 3 KEYNOTE-522 Trial: TNBC Updates

Nebraska Oncology Society

C. Dang

77 views
09:57

ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…

ASCO 2022 Conference Coverage

C. Dang

201 views
01:06

Lecture Summary - ASCO 2022 Preliminary Analysis of an Expanded Acce…

ASCO 2022 Conference Coverage

C. Dang

43 views
05:41

ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan Doubles PFS in MB…

ecancer

S. Modi

44 views
05:57

ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan vs. Treatment of …

ecancer

S. Modi

224 views
06:32

ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia …

ASCO 2022 Conference Coverage

S. Shen

370 views
01:37

Lecture Summary - ASCO 2022 on Characterization of Alpelisib-Associa…

ASCO 2022 Conference Coverage

S. Shen

18 views
20:08

HER2- Directed Targeted Agents for Brain Metastasis in Metastatic Br…

Memorial Sloan Kettering Cancer Center

N. Iyengar

663 views
28:05

2022 Inherited Breast Cancer Risk Assessment and Reduction: What's N…

University of Kansas Cancer Center Post San Antonio Review

M. Robson

48 views
53:46

HR+ Breast Cancer: Individualizing Therapy With CDK 4/6 Inhibitors

PleXus Communications

K. Jhaveri

349 views
07:16

SABCS 2021 Results of a Prospective Screening Study: Impact of Race …

SABCS 2021 Conference Coverage on VuMedi

A. Barrio

18 views
13:08

SABCS 2021 Updates on Neratinib + Fulvestrant + Trastuzumab for HR+/…

SABCS 2021 Conference Coverage on VuMedi

K. Jhaveri

283 views
24:21

SABCS 2021 Update on Oligoprogressive Disease in BC: Treating Locall…

SABCS 2021 Conference Coverage on VuMedi

A. Xu

509 views
20:23

Will Surgery Be a Part of Breast Cancer Treatment in the Future?

Memorial Sloan Kettering Cancer Center

M. Morrow

3.8K views
26:50

CAR-T Cell Therapy for Breast Cancer: Types of T-Cell Therapy, Ident…

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

S. Modi

831 views